Drug Nod Delays Not Hampering South Korean Pharma Position
According to a survey from Fitch Solutions, South Korea's pharmaceutical market attractiveness is expected to stay strong despite ongoing concerns about the country's slow...
In-Person Meetings To Begin By The FDA Starting February 13
FDA has recently announced that it is going to restart its in-person meetings that are face-to-face beginning February 13 with industry sponsors of biologics...
Medicine Patient Pool For 2023-25 To Curb Drug Inequalities
A novel strategy for 2023–25 adopted by the Medicines Patent Pool looks to lessen the inequalities in access by way of enhancing the affordability...
Acute Leukaemia May Find Saviour In PIK-75, An Existing Drug
National University of Singapore researchers have gone ahead and revisited a drug which they believe can be a problem solver when it comes to...
The Top 3 Questions Looming Over Pharma Sector This 2023
2023 can be challenging for the pharmaceutical sector as it will mark the rollout of certain important drug pricing reforms across the US which...
FDA Comes With A Research Map Concerning Biosimilars Program
The FDA has gone on to release the Biosimilar User Fee Amendments III Regulatory Science Pilot Program, called the Research Roadmap, to give out...
Getting Immunotherapy Work In Case of Pancreatic Cancer
One of the latest studies that takes into account the tumour microenvironment of pancreatic cancer puts forth the cause that tumour cells are resistant...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...




















